Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.58B |
| 2 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$1.43B |
| 3 |
Boeing
BA
|
+$283M |
| 4 |
CrowdStrike
CRWD
|
+$251M |
| 5 |
Coinbase
COIN
|
+$235M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$845M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$837M |
| 3 |
Broadcom
AVGO
|
+$691M |
| 4 |
NVIDIA
NVDA
|
+$662M |
| 5 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$660M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 93.75% |
| 2 | Technology | 1.85% |
| 3 | Consumer Discretionary | 1.02% |
| 4 | Financials | 0.76% |
| 5 | Communication Services | 0.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
11301
Peloton Interactive
PTON
$2.33B
| $54.1K | ﹤0.01% |
11,553
-2,316,210
| -100% | -$9.1M |
|
11302
Minerva Neurosciences
NERV
$245M
| $54K | ﹤0.01% |
20,224
+8,286
| +69% | +$24.1K |
|
|
LILM
11303
PUT
DELISTED
Lilium N.V. Class A Ordinary Shares
LILM
| $54K | ﹤0.01% |
70,100
-5,700
| -8% | -$4.6K |
|
11304
Identive
INVE
$68.1M
| $53.8K | ﹤0.01% |
+15,251
| New | +$55.8K |
|
11305
CALL
Celularity
CELU
$60.8M
| $53.8K | ﹤0.01% |
18,100
-38,000
| -68% | -$112K |
|
|
JBIO
11306
PUT
Jade Biosciences
JBIO
$1.35B
| $53.7K | ﹤0.01% |
734
-469
| -39% | -$30.3K |
|
11307
CALL
Playboy Inc
PLBY
$144M
| $53.4K | ﹤0.01% |
70,200
-15,900
| -18% | -$11.4K |
|
11308
PUT
Leslie's
LESL
$4.99M
| $53.1K | ﹤0.01% |
840
-7,550
| -90% | -$466K |
|
11309
MeiraGTx Holdings
MGTX
$1.36B
| $53.1K | ﹤0.01% |
+12,724
| New | +$55K |
|
|
FSP
11310
Franklin Street Properties
FSP
$42.8M
| $52.9K | ﹤0.01% |
29,882
+19,532
| +189% | +$32.4K |
|
11311
CBAK Energy Technology Ltd
CBAT
$76.5M
| $52.8K | ﹤0.01% |
42,205
-46,457
| -52% | -$52.1K |
|
11312
PUT
Acumen Pharmaceuticals
ABOS
$219M
| $52.3K | ﹤0.01% |
21,100
-12,300
| -37% | -$33.4K |
|
11313
Destination XL Group
DXLG
$34.3M
| $52K | ﹤0.01% |
+17,678
| New | +$55K |
|
|
SJT
11314
CALL
San Juan Basin Royalty Trust
SJT
$127M
| $51.1K | ﹤0.01% |
13,800
-42,700
| -76% | -$160K |
|
11315
Gogoro
GGR
$51.6M
| $50.9K | ﹤0.01% |
4,803
+4,052
| +540% | +$98.5K |
|
|
AGIG
11316
Abundia Global Impact Group
AGIG
$42.8M
| $50.9K | ﹤0.01% |
4,625
-1,172
| -20% | -$13.7K |
|
11317
Network-1 Technologies
NTIP
$35.2M
| $50.9K | ﹤0.01% |
36,331
+7,509
| +26% | +$11.8K |
|
11318
CALL
Erasca
ERAS
$6.82B
| $50.8K | ﹤0.01% |
+18,600
| New | +$52.4K |
|
11319
CALL
AirSculpt Technologies
AIRS
$188M
| $50.7K | ﹤0.01% |
10,000
-9,400
| -48% | -$40.8K |
|
11320
TScan Therapeutics
TCRX
$50.8M
| $50.7K | ﹤0.01% |
+10,176
| New | +$61.4K |
|
|
KRON
11321
DELISTED
Kronos Bio
KRON
| $50.2K | ﹤0.01% |
50,249
-54,036
| -52% | -$59.8K |
|
|
CRDL
11322
Cardiol Therapeutics
CRDL
$241M
| $50.2K | ﹤0.01% |
25,346
-40,834
| -62% | -$84.7K |
|
|
ORLA
11323
DELISTED
Orla Mining
ORLA
| $50.1K | ﹤0.01% |
+12,521
| New | +$49.6K |
|
11324
PUT
Vivani Medical
VANI
$126M
| $50.1K | ﹤0.01% |
42,800
-8,500
| -17% | -$10.6K |
|
11325
Entravision Communication
EVC
$747M
| $49.9K | ﹤0.01% |
24,098
-19,070
| -44% | -$38.1K |
|
Similar funds
Jeff Yass's Q3 2024 Portfolio in Review
As of Q3 2024, Jeff Yass held 13,475 positions worth $572B, up 6.6% from $537B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Jeff Yass's Q3 2024 filing shows 1,572 new, 5,247 increased, 4,924 reduced and 1,625 closed positions. Its largest new stake was Camtek: 408,771 shares worth $32.6M. The largest sale was Apple, an estimated $845M.
By sector, the portfolio is most concentrated in Miscellaneous at 94% of assets, up from 93% a quarter earlier, followed by Technology and Consumer Discretionary.
- Jeff Yass's largest Q3 2024 buy was Camtek: 408,771 shares worth $32.6M.
- Jeff Yass added most to State Street SPDR S&P 500 ETF Trust in Q3 2024, an estimated $2.58B increase.
- Jeff Yass's biggest Q3 2024 reduction was Apple, cutting an estimated $845M.
- Jeff Yass fully exited iShares Convertible Bond ETF in Q3 2024, selling an estimated $80.5M.
- Jeff Yass's ten largest holdings make up 25% of its $572B portfolio in Q3 2024.
- Jeff Yass opened 1,572 new positions and closed 1,625 in Q3 2024.
- Jeff Yass's portfolio value rose 6.6% quarter-over-quarter to $572B.
Based on Susquehanna International Group's 13F filing for Q3 2024, filed 14 Nov 2024.